Elevated CRP levels are associated with metabolic disease, including dyslipidemia, diabetes, and metabolic syndrome (Cho & Lee, 2022), and are used to assess the risk of cardiovascular diseases at large (Han et al., 2022). This evidence concerns the gene CRP and metabolic syndrome.